PG-010 is composed of a cyclic peptide that binds to the thrombopoietin receptor (TPOR) and functions as a growth factor substitute peptide, demonstrating agonistic activity towards TPOR.
*This is for illustrative purpose.
Recombinant TPO and PG-010 activities were compared using ERK phosphorylation and reporter gene activation under JAK2-STAT5 signaling pathway. The results indicated that PG-010 demonstrated activity nearly equivalent to TPO on a molar basis, showing similar activity at 2.6 times less concentrations than recombinant TPO based on mass concentration (ng/mL).
| Formulation | Lyophilized |
|---|---|
| Storage Condition | ≦-20℃ |
| Purity | ≧95% (HPLC) |
| Molecular Weight | 7148.02 (acetate) |
| Product Size | 10 µg per a glass vial (*equivalent to rTPO 26 µg) 25 µg per a glass vial (*equivalent to rTPO 65 µg) |
We offer our products worldwide through the following distributors. Please contact the relevant distributors depending on your region.
Please note that currently, we offer all products except PG-009 through distributors. For inquiries regarding PG-009 and bulk orders, please contact us directly through the inquiry form on our website.
| Scientist.com | https://app.scientist.com/inventory?query=PeptiGrowth&commit=Next |
|---|---|
| Stratech | https://www.stratech.co.uk/ |
| Tebubio | https://www.tebubio.com/search?q=PeptiGrowth |
| Genesee Scientific | https://geneseesci.com/ |
| Abacus dx | https://www.abacusdx.com/ |
PeptiGrowth Inc.
Nihonbashi Life Science Building 7, 9-10, Nihonbashi Horidomecho 1-chome, Chuo-ku, Tokyo 103-0012, Japan
TEL +81-70-7789-3905